Pure Global: Costa Rica's MedTech Gambit - The New Local-Only Fast Track episode artwork

EPISODE · Apr 23, 2026 · 1 MIN

Pure Global: Costa Rica's MedTech Gambit - The New Local-Only Fast Track

from LATAM MedTech Insights

This week, we dive into a game-changing development out of Costa Rica. Long known as a premier manufacturing hub for MedTech, the country just launched the "Medical Device Innovation Pathway" (MDIP), a new accelerated registration process exclusively for locally manufactured devices. This move could redefine market entry strategies across Latin America, offering unprecedented speed but with significant new hurdles. We unpack what the MDIP truly entails, moving beyond the headlines to analyze the specific, challenging requirements hidden within this new regulation. This episode is essential for any MedTech leader who manufactures in, or is considering, Costa Rica as a strategic base for their LATAM operations. Case Study: Imagine you've invested millions in a state-of-the-art manufacturing facility in Costa Rica. The new MDIP promises a rapid launch into the LATAM market, but it comes with surprise local audits and stringent data-sharing clauses that your global compliance framework is not prepared for. Is this accelerated pathway a golden opportunity or a regulatory trap? What you will learn: - What are the specific terms of Costa Rica's new Medical Device Innovation Pathway? - Why is this new regulation a strategic "gambit" for the country's economy? - What are the top three hidden compliance traps in the new fast-track process? - How do the MDIP's quality system requirements differ from ISO 13485? - Could this "local-first" regulatory model be adopted by other LATAM countries? - How will this impact decisions for siting new manufacturing facilities in the region? - What are the critical questions to ask your regulatory team about this development today? At Pure Global, we specialize in turning complex regulatory challenges into clear market access strategies. Our team of local experts in Latin America provides on-the-ground support for everything from initial regulatory strategy and technical dossier submission to quality assurance and post-market surveillance. We help you navigate intricate local requirements like Costa Rica's MDIP, ensuring your path to market is both fast and compliant. Don't let regulatory surprises derail your launch. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.

Episode metadata supplied by the publisher feed · Published Apr 23, 2026

Embed this episode

NOW PLAYING

Pure Global: Costa Rica's MedTech Gambit - The New Local-Only Fast Track

0:00 1:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of LATAM MedTech Insights?

This episode is 1 minute long.

When was this LATAM MedTech Insights episode published?

This episode was published on April 23, 2026.

Can I download this LATAM MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!